ACM Live Webinar: Exploring the role of domperidone for boosting breast milk supply
The presentation will address the following learning objectives:
- Describe benefits and risks associated with using domperidone as a galactagogue
- Outline advantages and disadvantages to using domperidone over other galactagogues
- Discuss controversies and risk management approaches for using domperidone safely in clinical practice
- Summarise key evidence-practice gaps as they relate to domperidone use in clinical practice
Presented by Dr Luke Grzeskowiak
Dr Luke Grzeskowiak is a clinical pharmacist at Flinders Medical Centre in Adelaide and a Senior Research Fellow in the Robinson Research Institute at the University of Adelaide. He is passionate about improving health outcomes for mothers and babies through the development and promotion of more effective and safer approaches towards medicines use.
Luke is currently the lead investigator on a number of projects examining the use of domperidone to boost breast milk supply in clinical practice, predictors of treatment response to domperidone, and causes of low breast milk supply. He is also the lead investigator on a large clinical trial comparing the effects of different doses of domperidone in the treatment of low breast milk supply. He has published widely on the topic of treatment for low breast milk supply, with many of these publications cited in clinical practice guidelines locally and internationally.
His presentation will review current evidence regarding the use of domperidone for increasing breast milk supply.
Non-ACM Members can register now for $33. Recording will be available for $55.
Webinar will start at 1pm AEST
1 CPD hour